Skip to main content
. 2020 Apr 23;72(2):584–594. doi: 10.1002/hep.31047

Figure 2.

Figure 2

vWF‐Ag allows additional risk stratification on the waiting list for OLT. (A) Continuous risk for 3‐month mortality (OR) was calculated for vWF‐Ag and is visualized. VWF‐Ag was incorporated as described in the main text. (B) Indeed, incorporation of vWF‐Ag was able to increase the AUC of MELD‐Na alone for prediction of 3‐month mortality on the waiting list. (*P < 0.05, **P < 0.005).